Advertisement

Different Factors in Death from Coronary Disease

  • D. G. Julian
Part of the NATO Advanced Science Institutes Series book series (NSSA, volume 62)

Abstract

It might be thought easy to determine the mechanism of death in a particular case, but reflection will reveal that one’s belief as to the cause of death depends upon one’s discipline and, indeed, one’s philosophy. Thus, the answer will differ depending on whether one is a biochemist, physiologist, physicist, pathologist, clinician or, indeed, a psychologist, priest or astrologer. My view will be that of a clinician who has observed many patients dying of coronary disease and who has had the opportunity, in association with his pathological colleagues of studying the macroscopic and microscopic features visible after death. The clinician is at a disadvantage insofar as he cannot observe the fundamental biochemical or biophysical abnormalities in the myocardium; on the other hand, he may be able to observe the electrical phenomena of the heart and its haemodynamic performance immediately prior to, and at the time of, death.

Keywords

Ventricular Fibrillation Coronary Artery Occlusion Coronary Care Unit Coronary Artery Spasm Trial Research Group 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. ADGEY, A.A.J., GEDDES, J.S., MULHOLLand, H.C., KEEGAN, D.A.J. and PANTRIDGE, J.F. (1968): Incidence, significance and management of early bradyarrhythmias complicating acute myocadial infarction. Lancet ii: 1097–101.CrossRefGoogle Scholar
  2. Anturan Reinfarction Italian Study (1982): Sulphinpyrazone in postmyocardial infarction. Lancet 1: 237–242.Google Scholar
  3. Anturane Reinfarction Trial Research Group (1980): Sulfinpyrazone in the prevention of sudden death after myocardial infarction. N. Eng. J. Med. 302: 250–56.CrossRefGoogle Scholar
  4. B-Blocker Heart Attack Trial Research Group (1982): A randomized trial of propranolol in patients with acute myocardial infarction, JAMA 247: 1707–14.CrossRefGoogle Scholar
  5. COBB, L.A., WERNER, J.A. and TROBAUGH, G.B. (1980): Sudden cardiac death. Mod. Conc. Cardiovasc. Dis. 49: 31–36.Google Scholar
  6. CONTI, C.R., and CURRY, R.C. (1980): Coronary artery spasm and myocardial ischaemia. Mod. Conc. Cardiovasc. Dis 49: 1–6.Google Scholar
  7. DAVIES, M.J. (1981): Pathological view of sudden cardiac death. Brit. Heart J. 45: 88–96.CrossRefGoogle Scholar
  8. GRADMAN, A.H., BELL, P.A. and DE BUSK, R.F. (1977): Sudden death during ambulatory monitoring. Circulation 55: 210–211.Google Scholar
  9. HARRIS, A.S. (1950): Delayed development of ventricular ectopic rhythms following experimental coronary occlusion. Circulation 1: 318.Google Scholar
  10. HARRIS, A.S. and ROJAS, A.G. (1943): The initiation of ventricular fibrillation due to coronary occlusion. Expt. Med. Surg. 1: 105.Google Scholar
  11. KARAGUENZIAN, H.S. and WIT, A.L. (1980): Studies on ventricular arrhythmias in animal models of ischaemic heart disease in “Sudden Death” H.E. Kulbertus and H.J.J. Wellens (Eds.) pp. 68–88, Martinus Nijhoff, The Hague.Google Scholar
  12. KULLER, L.H., PERPER, P.A. and COOPER, M.C. (1975): Sudden and unexpected death due to arteriosclerotic heart diseases. In: Modern Trend Cardiology 3rd ed. Oliver, M.F. (Ed.) pp. 292–332. Butterworth, London.Google Scholar
  13. LAWRIE, D.M., HIGGINS, M.R., GODMAN, M.J., OLIVER, M.F., JULIAN, D.G. and DONALD, K.W. (1968): Ventricular fibrillation complicating myocardial infarction. Lancet ii 523–8.CrossRefGoogle Scholar
  14. LIE, K.I., LIEN, K.L., SCHUILENBERG, and DAVID, G.K., and DURRER, D. (1978): Early identification of patients developing late in-hospital ventricular fibrillation after discharge from the coronary care unit. Amer. J. Cardiol. 41: 674–7.CrossRefGoogle Scholar
  15. MYERS, A. and DEWAR, H.A. (1975): Circumstances attending 100 sudden deaths from coronary disease with coroner’s necropsies. Brit. Heart J. 37: 1133–63CrossRefGoogle Scholar
  16. OLIVA, P.B. and BRECKINRIDGE, G.C. (1977): Acute myocardial infarction with normal and near normal coronary arteries. Am. J. Cardiol. 40: 1000–1007.CrossRefGoogle Scholar
  17. RENTROP, P., BLANKE, H., KARSCH, K.R., KAISER, H., KOSTERING, H. and LEITZ, K. (1981): Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris. Circulation 63: 307–316.CrossRefGoogle Scholar
  18. The Norwegian Multicenter Study Group (1981): Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N. Eng J. Med. 304: 801–7.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1983

Authors and Affiliations

  • D. G. Julian
    • 1
  1. 1.Department of Cardiology, Freeman HospitalUniversity of Newcastle upon TyneNewcastle upon TyneUK

Personalised recommendations